Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

Delayed Data
As of Oct 21
 -0.10 / -0.45%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for Valeant Pharmaceuticals have a median target of 34.50, with a high estimate of 81.00 and a low estimate of 16.00. The median estimate represents a +57.10% increase from the last price of 21.96.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Hold stock in Valeant Pharmaceuticals. This rating has held steady since October, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 25.73%
Growthannually -36.16%


Growthquarterly 3.92%
Growthannually -5.01%
Key to the earnings and sales forecast charts.